Volume 4, Number 3, September 2003

New-onset diabetes and antihypertensive therapy: comments on ALLHAT trial
Cristina Sierra, Luis M Ruilope

The development of new-onset diabetes is frequent during the follow-up of treated hypertensive patients. The prevalence of such an event seems to differ depending on the type of antihypertensive therapy used to control blood pressure. Diuretics and b-blockers and their association are particularly harmful in this regard. On the contrary, calcium channel blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, alone or in association with diuretics, are associated with a lower prevalence of this metabolic complication. These statements are confirmed by data from the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) study. Long-term studies are required to determine the relevance of development of new-onset diabetes in treated hypertensive patients.

JRAAS 2003;4:169-170.

View full PDF article (open in new window)
Export to bibliographic software or plain text
Email this article

Right click on this DOI link and copy link to cite this article (What is a DOI link?)